维普中文期刊产品整合服务
27篇 您的检索式:作者名="Balakumaran"
    题名 作者 年代 出处 被引量
1Routine diagnosis of intestinal tuberculosis and Crohn's disease in Southern India显示文摘AIM:To investigate whether routinely measured clinical variables could aid in differentiating intestinal tuberculosis(ITB)from Crohn’s disease(CD).METHODS:ITB and CD patients were prospectively included at four South Indian medical centres from October 2009 to July 2012.Routine investigations included case history,physical examination,blood biochemistry,ileocolonoscopy and histopathological examination of biopsies.Patients were followed-up after 2 and 6 mo of treatment.The diagnosis of ITB or CD was re-evaluated after 2 mo of antituberculous chemotherapy or immune suppressive therapy respectively,based on improvement in signs,symptoms and laboratory variables.This study was considered to be an exploratory analysis.Clinical,endoscopic and histopathological features recorded at the time of inclusion were subject to univariate analyses.Disease variables with sufficient number of recordings and P<0.05 were entered into logistic regression models,adjusted for known confounders.Finally,we calculated the odds ratios with respective confidence intervals for variables associated with either ITB or CD.RESULTS:This study included 38 ITB and 37 CD patients.Overall,ITB patients had the lowest body mass index(19.6 vs 22.7,P=0.01)and more commonly reported weight loss(73%vs 38%,P<0.01),watery diarrhoea(64%vs 33%,P=0.01)and rural domicile(58%vs 35%,P<0.05).Endoscopy typically showed mucosal nodularity(17/31 vs 2/37,P<0.01)and histopathology more frequently showed granulomas(10/30vs 2/35,P<0.01).The CD patients more frequently reported malaise(87%vs 64%,P=0.03),nausea(84%vs 56%,P=0.01),pain in the right lower abdominal quadrant on examination(90%vs 54%,P<0.01)and urban domicile(65%vs 42%,P<0.05).In CD,endoscopy typically showed involvement of multiple intestinal segments(27/37 vs 9/31,P<0.01).Using logistic regression analysis we found weight loss and nodularity of the mucosa were independently associated with ITB,with adjusted odds ratios of 8.6(95%CI:2.1-35.6)and 18.9(95%CI:3.5-102.8)respectively.Right lower abdominal quadrant pain on examination and involvement of≥3 intestinal segments were independently associated with CD with adjusted odds ratios of 10.1(95%CI:2.0-51.3)and 5.9(95%CI:1.7-20.6),respectively.CONCLUSION:Weight loss and mucosal nodularity were associated with ITB.Abdominal pain and excessive intestinal involvement were associated with CD.ITB and CD were equally common.Geir Larsson Thrivikrama Shenoy Ramalingom Ramasubramanian Leena Kondarappassery Balakumaran Milada Cvancarova Smstuen Gunnar Aksel Bjune Bjφrn Allan Moum 2014World Journal of Gastroenterology2014,20,17:5
2In vivo transter of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages显示文摘Pawelezyk E Jordan EK Balakumaran A 2009PLoS One2009,4,8:1
3Verapamilstereoisomers induce antiproliferative effects in vascular smoothmuscle cells via autophagy 显示文摘Salabei JK Balakumaran A Frey JC 2012Toxicol Appl Pharmacol2012,262,3:1
4Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer显示文摘Hsu D S Balakumaran B S Acharya C R 2007J Clin Oncol2007,25,28:1
5MYC Activity miti- gates response to Rapamycin in prostate cancer through 4EBPI- mediated inhibition of autophagy 显示文摘Balakumaran BS Porrello A Hsu DS et at 2009Cancer Rcs2009,69,19:1
6Bone marrow microenvironment in myelomagenesis:its potential role in early diagnosis显示文摘Balakumaran A Robey PG Fedarko N 0,,04:1
7In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages显示文摘Pawelczyk E Jordan E K Balakumaran A 2009PLoS One2009,4,8:1
8Verapamil stereoisomers induce antiproliferative effects in vascular smooth muscle cells via autophagy 显示文摘Salabei JK Balakumaran A Frey JC 2012Toxicol Appl Phar- macol2012,262,:1
9MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy显示文摘Balakumaran BS Porrello A Hsu DS 2009Cancer Res2009,69,19:1
10Analysis of a large single-center experience with robot-assisted pyeloplasty显示文摘Tobis S Venigalla S Balakumaran K International Journal of Urology0,,:1
11Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis显示文摘Balakumaran A Robey PG Fedarko N 2010Expert Rev Mol Diagn2010,10,:1
12Characteri- zing the developmental pathways TTF-I, NKX2-8, and PAX9 in lung cancer显示文摘Hsu DS Acharya CR Balakumaran BS 2009Pro Natl Acad SCI USA2009,106,13:1
13Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis 显示文摘Balakumaran A Robey PG Fedarko N Expert Rev Mol Dian0,10,4:1
14The dilemma of diagnosing the cause of hypernatraemia:drinking habits vs diabetes insipidus显示文摘 BALAKUMARAN A BICHET D G 2004Nephrol Dial Transplant2004,19,12:1
15Drug enterocyte adducts:possible causal factor for diclofenac enteropathy in rats显示文摘Atchison CR West AB Balakumaran A 0,,:1
16Smoldering (asymptomatic) multiple myeloma: revisiting the clinical dilemma and looking into the future显示文摘Waxman AJ Kuehl M Balakumaran A 2010Clin Lymphoma Myeloma Leuk2010,10,4:1
17In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages显示文摘Pawelczyk E Jordan EK Balakumaran A 2009PLoS One2009,4,8:1
18Analysis of a large single-center experience with robot-assisted pyeloplasty显示文摘Tobis S Venigalla S Balakumaran K 2013Int J Urol2013,20,2:1
19Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis显示文摘Balakumaran A Robey PG Fedarko N 2010Expert Rev Mol Diagn2010,10,4:1
20MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy显示文摘Balakumaran BS Porrello A Hsu DS 2009Cancer Res2009,69,19:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费